An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer | BMC Cancer | Full Text

An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer | BMC Cancer | Full Text

An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer

Combining anti-cancer therapies with orthogonal modes of action, such as direct cytotoxicity and immunostimulatory, hold promise for expanding clinical benefit to patients with metastatic disease. For instance...

Authors:Qing Wang, Zhijun Wang, Yan Wu and David J. Klinke II

Citation:BMC Cancer 2020 20:26

Content type:Research Article

Published on: 8 January 2020

• ViewFull Text
 
• ViewPDF